Looking for biologic drug patents? See BiologicPatentWatch.com

DrugPatentWatch

Drug Patent Expirations this Month

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$2,495/ year
$495/ month

Premium Plan

$1,995/ year
$445/ month

Basic Plan

$1,195/ year
$295/ month

Drug Patent Expirations in October 2014

*Drugs may be covered by multiple patents
Tradename Applicant Generic Name Patent No. Patent Expiration
DENAVIR
Denco Asset
penciclovir sodium
6,124,304Oct 4, 2014
DENAVIR
Denco Asset
penciclovir sodium
5,866,581Oct 4, 2014
REMODULIN
United Therap
treprostinil
5,153,222Oct 6, 2014
SYMBICORT
Astrazeneca
budesonide; formoterol fumarate dihydrate
5,674,860Oct 7, 2014
SUPRANE
Baxter Hlthcare
desflurane
5,617,906*PEDOct 8, 2014
CHIROCAINE
Purdue Pharma Lp
levobupivacaine hydrochloride
5,708,011Oct 13, 2014
ATROVENT HFA
Boehringer Ingelheim
ipratropium bromide
5,676,930Oct 14, 2014
VARITHENA
Provensis
polidocanol
RE40640Oct 14, 2014
COARTEM
Novartis
artemether; lumefantrine
5,677,331Oct 14, 2014
CLIMARA PRO
Bayer Hlthcare
estradiol; levonorgestrel
5,676,968Oct 14, 2014
VARITHENA
Provensis
polidocanol
RE38919Oct 14, 2014
TYVASO
United Therap
treprostinil
5,153,222Oct 16, 2014
ORENITRAM
United Therap
treprostinil diolamine
5,153,222Oct 16, 2014
TOBI
Novartis Pharms
tobramycin
5,508,269Oct 19, 2014
BACTROBAN
Glaxosmithkline
mupirocin calcium
6,025,389Oct 20, 2014
CYCLOSET
Veroscience
bromocriptine mesylate
5,679,685Oct 21, 2014
IMODIUM MULTI-SYMPTOM RELIEF
Mcneil
loperamide hydrochloride; simethicone
5,679,376Oct 21, 2014
AUBAGIO
Sanofi Aventis Us
teriflunomide
5,679,709Oct 21, 2014
PRAVIGARD PAC (COPACKAGED)
Bristol Myers Squibb
aspirin; pravastatin sodium
5,622,985*PEDOct 22, 2014
PRAVACHOL
Bristol Myers Squibb
pravastatin sodium
5,622,985*PEDOct 22, 2014
VELCADE
Millennium Pharms
bortezomib
6,297,217Oct 28, 2014
RYTHMOL SR
Glaxosmithkline Llc
propafenone hydrochloride
5,681,588Oct 28, 2014
VELCADE
Millennium Pharms
bortezomib
6,747,150Oct 28, 2014
VELCADE
Millennium Pharms
bortezomib
6,083,903Oct 28, 2014
VELCADE
Millennium Pharms
bortezomib
7,119,080Oct 28, 2014
VELCADE
Millennium Pharms
bortezomib
6,617,317Oct 28, 2014
IPLEX
Insmed
mecasermin rinfabate recombinant
5,681,818Oct 28, 2014
WELCHOL
Daiichi Sankyo
colesevelam hydrochloride
5,919,832*PEDOct 29, 2014
WELCHOL
Daiichi Sankyo
colesevelam hydrochloride
6,433,026*PEDOct 29, 2014
WELCHOL
Daiichi Sankyo
colesevelam hydrochloride
5,917,007*PEDOct 29, 2014
WELCHOL
Daiichi Sankyo
colesevelam hydrochloride
7,101,960*PEDOct 29, 2014
WELCHOL
Daiichi Sankyo
colesevelam hydrochloride
6,066,678*PEDOct 29, 2014
WELCHOL
Daiichi Sankyo
colesevelam hydrochloride
5,679,717*PEDOct 29, 2014
WELCHOL
Daiichi Sankyo
colesevelam hydrochloride
6,784,254*PEDOct 29, 2014
first patents previous patents next patents last patents
Share:

« Back to Innovation Infographics

Database Preview

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc